-
Featured
Coronary Artery Disease: Pathways and Subtypes
Precision medicine can help answer whether or not current heart disease treatment paradigms optimally address genetic heterogeneity.
-
Featured
Hope for High-risk Coronary Artery Patients
Many patients with complex CAD are high-risk and ineligible for surgical treatment. Alternative and advanced interventions at Mass General are proving to be effective.
-
Featured
Coronary Artery Disease - Reporting & Data System (CAD-RADS)
Massachusetts General Hospital clinicians discuss a male age 55 that presents with left sided chest pain and has a history of hypertension and hyperlipidemia.
-
Better Guidelines Needed to Distinguish Individuals at Elevated Polygenic Risk of CAD
Current guideline-based strategies for estimating a patient's risk of coronary artery disease do not account fully for inherited susceptibility.
-
Advanced Fibrosis Predicts Nonfatal CVD in NAFLD Patients
Advanced fibrosis accounts for two-thirds of the risk of new-onset cardiovascular disease in patients with nonalcoholic fatty liver disease.
-
Genome-wide Polygenic Score Predicts CV Events in Secondary Prevention Population
A previously validated genome-wide polygenic score for coronary artery disease predicted major cardiovascular events among patients with high-risk vascular disease.
Coronary Artery Disease contributors
-
Douglas E. Drachman, MD
Director, Cardiovascular Fellowship Program, Director, Interventional Cardiology Fellowship Program
Recent Article
ACC 2019: A Media Roundup
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Interventional Treatment of Chronic Total Occlusion
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Caution Needed When Interpreting BNP During Sacubitril/Valsartan Treatment
-
Malissa J. Wood, MD
Co-Director, Corrigan Women's Heart Health Program
Recent Article
Leveraging Social Media in Medicine
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
